Results 231 to 240 of about 53,534 (265)
Some of the next articles are maybe not open access.
2018
Over the past three decades, new strategies have evolved to optimize coronary revascularization techniques. As such, both coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have become standard treatments. Following the publication of trials showing a mortality benefit from CABG over PCI in only certain complex patient ...
Javier Cuesta +4 more
+5 more sources
Over the past three decades, new strategies have evolved to optimize coronary revascularization techniques. As such, both coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have become standard treatments. Following the publication of trials showing a mortality benefit from CABG over PCI in only certain complex patient ...
Javier Cuesta +4 more
+5 more sources
Stent malapposition generates stent thrombosis: Insights from a thrombosis model
International Journal of Cardiology, 2022Currently, there exists differing conclusions on the role of acute stent malapposition and its role in stent thrombosis (ST). The European Association of Percutaneous Cardiovascular Interventions (EAPCI) consensus recommends that acute malapposition
Jaryl Chen Koon, Ng +5 more
openaire +2 more sources
Stent selection to minimize the risk of stent thrombosis
Current Opinion in Cardiology, 2014Compared with bare metal stents (BMS), first-generation drug-eluting stents (DES) have significantly reduced the risk of ischemia-driven target vessel revascularization, but have been associated with an increased risk of very late (beyond 1 year) stent thrombosis.
Palmerini, Tullio +2 more
openaire +2 more sources
Revista clinica espanola, 2008
Stent thrombosis (ST) is an uncommon but potentially lethal complication of coronary endoprothesis. Clinical trials have not shown differences in the incidence of early and late thrombosis among bare-metal stents and drug-eluting stents. Very late stent thrombosis occurs more than a year after stent implantation and is more specific of drug-eluting ...
D, Martí Sánchez +4 more
openaire +1 more source
Stent thrombosis (ST) is an uncommon but potentially lethal complication of coronary endoprothesis. Clinical trials have not shown differences in the incidence of early and late thrombosis among bare-metal stents and drug-eluting stents. Very late stent thrombosis occurs more than a year after stent implantation and is more specific of drug-eluting ...
D, Martí Sánchez +4 more
openaire +1 more source
The Journal of the Association of Physicians of India, 2009
Technology of drug-eluting stent (DES) implantation is relatively young. DES have remarkably reduced the incidence of stent-restenosis (SRS) and the need for target vessel revascularization (TVR). Yet it has added a small but significant risk of late and very late stent thrombosis (ST).
S, Gupta, M M, Gupta
openaire +1 more source
Technology of drug-eluting stent (DES) implantation is relatively young. DES have remarkably reduced the incidence of stent-restenosis (SRS) and the need for target vessel revascularization (TVR). Yet it has added a small but significant risk of late and very late stent thrombosis (ST).
S, Gupta, M M, Gupta
openaire +1 more source